Conmed Stock

Conmed Equity 2025

Conmed Equity

834.22 M USD

Ticker

CNMD

ISIN

US2074101013

WKN

886793

In 2025, Conmed's equity was 834.22 M USD, a 11.9% increase from the 745.5 M USD equity in the previous year.

Conmed Aktienanalyse

What does Conmed do?

Conmed Corporation is a leading medical technology company that offers a wide range of surgical instruments and devices for the fields of gastroenterology, endoscopy, orthopedics, gynecology, and electro surgery. The company was founded in 1970 and is headquartered in Utica, New York. The history of Conmed Corp began with the founding of Consolidated Medical Equipment, Inc. (CME) in 1970. The company initially started its business with the distribution of surgical instruments and devices for medical applications and quickly expanded in this field. In the 1980s, the company went public. In the 1990s, the company changed its name to Conmed Corporation and expanded its activities into the field of electro surgery, which has since become a major growth driver for the company. Today, Conmed Corp operates multiple manufacturing facilities worldwide and has sales offices in over 50 countries. The company is divided into four main business segments: gastroenterology, endoscopy, orthopedics, and electro surgery. The gastroenterology segment includes products for the diagnosis and treatment of gastrointestinal disorders, such as endoscopes, biopsy instruments, dilation balloons, trocars, and shears. In the endoscopy segment, Conmed Corp offers products for the diagnosis and treatment of digestive tract disorders, including endoscopes, biopsy instruments, dilation balloons, trocars, and shears. The orthopedics segment includes a wide range of surgical instruments and devices for the treatment of musculoskeletal disorders, including implants, bandages, bone plates, intramedullary nails, and others. Finally, the electro surgery segment is the fastest-growing segment of Conmed Corp and includes a wide range of devices for precision surgery, including electrocautery, electro surgery, endoscopy, and laparoscopy devices. Conmed Corp aims to develop innovative medical technologies that meet the needs of patients and healthcare professionals. The company places great emphasis on producing high-quality products that are reliable and safe. Conmed Corp is a successful company that continues to evolve and expand its product range to meet the rapidly evolving needs of the medical community. Conmed ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Conmed's Equity

Conmed's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Conmed's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Conmed's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Conmed's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Conmed’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Conmed stock

What is the equity of Conmed this year?

Conmed has equity of 834.22 M USD this year.

What was the equity of Conmed compared to the previous year?

The equity of Conmed has increased/decreased by 11.9% increased compared to the previous year.

What impact does a high equity have on investors of Conmed?

A high equity is advantageous for investors of Conmed as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Conmed?

A low equity can be a risk for investors of Conmed, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Conmed affect the company?

An increase in equity of Conmed can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Conmed affect the company?

A reduction in equity of Conmed can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Conmed?

Some factors that can affect the equity of Conmed include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Conmed so important for investors?

The equity of Conmed is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Conmed take to change the equity?

To change equity, Conmed can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Conmed pay?

Over the past 12 months, Conmed paid a dividend of 0.8 USD . This corresponds to a dividend yield of about 1.17 %. For the coming 12 months, Conmed is expected to pay a dividend of 0.82 USD.

What is the dividend yield of Conmed?

The current dividend yield of Conmed is 1.17 %.

When does Conmed pay dividends?

Conmed pays a quarterly dividend. This is distributed in the months of April, July, October, January.

How secure is the dividend of Conmed?

Conmed paid dividends every year for the past 16 years.

What is the dividend of Conmed?

For the upcoming 12 months, dividends amounting to 0.82 USD are expected. This corresponds to a dividend yield of 1.2 %.

In which sector is Conmed located?

Conmed is assigned to the 'Health' sector.

Wann musste ich die Aktien von Conmed kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Conmed from 1/3/2025 amounting to 0.2 USD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Conmed pay the last dividend?

The last dividend was paid out on 1/3/2025.

What was the dividend of Conmed in the year 2024?

In the year 2024, Conmed distributed 0.8 USD as dividends.

In which currency does Conmed pay out the dividend?

The dividends of Conmed are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Conmed

Our stock analysis for Conmed Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Conmed Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.